<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02816307</url>
  </required_header>
  <id_info>
    <org_study_id>2012-39</org_study_id>
    <secondary_id>2012-A01549-34</secondary_id>
    <nct_id>NCT02816307</nct_id>
  </id_info>
  <brief_title>Etiology of Endocarditis in Negative Blood Cultures</brief_title>
  <acronym>ENDOC</acronym>
  <official_title>Etiology of Endocarditis in Negative Blood Cultures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Infective endocarditis remains a serious disease that requires fast and specialized support
      in 2012. However, 24% of endocarditis unanswered etiology. The systematic use of new policy
      diagnosis, including (i) a systematic use of specific PCR techniques and (ii) the search for
      markers of inflammatory and tumoral diseases, should increase the number of positive
      etiological diagnosis of culture-negative samples.

      Secondly, because of the seriousness of the disease, the investigators were led to develop a
      new score: score for admission. This score, realized in less than 4 hours from the admission
      of the suspected patient with endocarditis, should allow for immediate probabilistic
      antibiotic treatment after completion of the diagnostic kit. The modified Duke score give its
      results in 4 to 7 days. With the score of admission thus diagnostic processes are accelerated
      and, where appropriate, empirical antibiotic therapy started.

      Primary: Evaluate the effectiveness of the new diagnostic strategy on etiological
      identification of endocarditis.

      Secondary: Validate the &quot;admission&quot; score compared to the modified Duke score.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The percentage of patients with an etiological diagnosis of endocarditis</measure>
    <time_frame>6 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The &quot;admission&quot; score</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the Duke score</measure>
    <time_frame>1day</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">1830</enrollment>
  <condition>Infective Endocarditis (IE)</condition>
  <arm_group>
    <arm_group_label>Infective endocarditis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>blood samples</intervention_name>
    <arm_group_label>Infective endocarditis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with endocarditis diagnostic kit prescribed

          -  Patient is more than 18 years old

          -  Patient who freely signed written informed consent.

          -  Patient affiliated to a health assurance

        Exclusion Criteria:

          -  Minor patient (&lt;18 years)

          -  Patient pregnant or breastfeeding

          -  Patient incapable or unable to consent

          -  Private patient of liberty or under court order

          -  Patient refusing to participate in the research
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>URIELLE DESALBRES</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique Hopitaux De Marseille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>JEAN PAUL CASALTA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique Hopitaux De Marseille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>jean-paul CASALTA</last_name>
    <email>jeanpaul.casalta@ap-hm.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>ALEXANDRA GIULIANI</last_name>
    <email>alexandra.giuliani@ap-hm.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assitance Publique Hopitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>jean paul casalta</last_name>
      <phone>0491387587</phone>
      <email>jeanpaul.casalta@ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>jean-paul casalta</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 21, 2016</study_first_submitted>
  <study_first_submitted_qc>June 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 28, 2016</study_first_posted>
  <last_update_submitted>June 24, 2016</last_update_submitted>
  <last_update_submitted_qc>June 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endocarditis</mesh_term>
    <mesh_term>Endocarditis, Bacterial</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

